caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1649401902

Priscilla Cooney

PRACTICEPIERCE COUNSELING ASSOCIATES, P.C.See all providers at this practice →
Nurse PractitionerKingston, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Priscilla Cooney's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
WILKES BARRE HOSPITAL COMPANY LLC114545
Bruce Saidman
Medical Oncology · Kingston, PA
104642
David Askin
Hematology-Oncology · Forest Hills, NY
33122
Guenadi Amoachi
Diagnostic Radiology · Wilkes Barre, PA
1728
RICHTERMAN, RONALD1315
Gil Hoang
Diagnostic Radiology · Dover, DE
1116
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
115
By payment type
Food and Beverage$2K
Education$35
PRESCRIBING · PART D · 2024
Total Rx claims
872
Beneficiaries
—
Total drug cost
$44K
Distinct drugs
25
Brand share
15.3%
Top prescribed drugs
Prochlorperazine Maleate79 claims
Levothyroxine Sodium77 claims
Exemestane70 claims
Potassium Chloride69 claims
Letrozole66 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
96.9
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group